on 02-08-2016 21:10
on 02-08-2016 21:10
http://www.bbc.co.uk/news/health-36946000http://www.bbc.co.uk/news/health-36946000 found this thought I'd share it here 
on 02-08-2016 21:49
on 02-08-2016 21:49
@Beenherebefore wrote:
@Cleoriff wrote:
Shocking that drug manufacturers are allowed to price their drugs so highly...
You know why that is and it's not shocking....it's a sensible business strategy which allows them to budget for future research. The price drops after the initial 3-5 years on the market.
It IS shocking from the perspective that Trusts are NOT given adequate funding for all the new drugs on the market.
Veritas Numquam Perit
on 02-08-2016 21:51
on 02-08-2016 21:51
02-08-2016 21:56 - edited 02-08-2016 21:58
02-08-2016 21:56 - edited 02-08-2016 21:58
@MI5 wrote:
If trusts didn't mismanage funds they'd have more to spend on patient care!
Don't be silly....they manage ok....They keep appointing people to the upper management echelons....and cut the nursing budget to do this......The fights I had when my funding was cut to my wards and education depts...
and that was then...Even worse now....
However that has absolutely nothing to do with allocated funding for pharmaceuticals. That comes from a seperate Government/NHS pot......
Veritas Numquam Perit
on 02-08-2016 22:04
on 02-08-2016 22:04
Oh ![]()
on 02-08-2016 22:09
on 02-08-2016 22:09
@Cleoriff wrote:
@Beenherebefore wrote:
@Cleoriff wrote:
Shocking that drug manufacturers are allowed to price their drugs so highly...
You know why that is and it's not shocking....it's a sensible business strategy which allows them to budget for future research. The price drops after the initial 3-5 years on the market.
It IS shocking from the perspective that Trusts are NOT given adequate funding for all the new drugs on the market.
But you said it was shocking that the drug mfgers were allowed to price their drugs do highly.......that's nothing to do with NHS funding !!
Any new product, especially drugs and chemicals, are priced high when new to (a) recover their R&D costs and (b) to finance future product R&D costs
on 02-08-2016 22:45
on 02-08-2016 22:45
. Yes if you want to get picky @Beenherebefore that is what I said......and believe me the price of some drugs does not always come down. This is the reason many hospitals and Primary care teams get all the bad publicity. Some are allowed funding for drug trials and others aren't Add to that there are new drugs being produced every day which every hospital would love to trial. The 'poorer' Trusts get no chance. Now if you are a teaching hospital....funding always appears to be found. The is a thorn in the side of everyone simply doing their best to care for the only people who matter, The patients....
I worked in a relatively small Trust. (3200 staff) They built the University College hospital 6 miles away. We lost services and funding for every single aspect of patient care.. It's a lottery. It should never be this way...That's all...
Veritas Numquam Perit
on 02-08-2016 22:59
on 02-08-2016 22:59
on 02-08-2016 23:09
on 02-08-2016 23:09
@Beenherebefore wrote:
I'm not getting picky.........
Ok...I am just passionate about something that's close to my heart. When I was in management I saw funds disappear and budgets slashed. I was part of the team that had to make some of those decisions. I had no control over the funding the Trust received.....but I knew what we got and how it had to be allocated.
Re the aspect of drug costs I would just refer you to this
"Pharmaceutical companies can extract enormous profits by controlling knowledge about how to make their drugs. Economic theory about market competition would suggest that, on seeing the huge profits being made, other producers would enter the market and produce the drug more cheaply. This is exactly what manufacturing companies have been doing in recent years, particularly in India, providing generic drugs to patients in the world's poorer countries. But this has been challenged by big pharmaceutical companies, which use their intellectual property rights to constrain the operation of market forces to their benefit, and to the disadvantage of the world's poor'
Veritas Numquam Perit
on 03-08-2016 09:21
on 03-08-2016 09:21
on 03-08-2016 09:26
on 03-08-2016 09:26
But much of those profits go into the pockets of the board and shareholders.